Since its founding in 2018, OneOncology has distinguished itself from MSO competitors by prioritizing service line expansion, enabling its partner practices to offer a broader range of advanced, patient-centered cancer care services within their communities.
This growth enables partner practices to offer advanced treatment options without requiring patients to seek care from multiple organizations. OneOncology facilitates this expansion by providing market and financial analysis, extensive clinical expertise, and access to capital. By offering capital resources, OneOncology empowers partner practices to invest in capital-intensive service lines that deliver significant value to patients — services that might otherwise be beyond the practice’s reach.
OneOncology’s willingness to prioritize and invest in service line expansion is unrivaled in the MSO space. These service lines include radiation therapy, cellular therapy, advanced imaging, lab, in-house pharmacy, and de novo clinic expansion into new markets. OneOncology has also demonstrated an ability to assist partner practices build collaborative partnerships with hospitals in their markets, effectively navigating relationships that can sometimes be adversarial, to ensure mutual benefit and improved patient care and access.
In 2024, OneOncology increased its industry-leading commitment to service line expansion across the OneOncology network, committing to funding over $58.5 million in capital across 25 initiatives for 13 partner practices.
Through investments in cancer care service expansion, including capital and expertise, OneOncology supports its partner practices plans to bring their patient community expanded access to advanced diagnostics and therapies — eliminating the need for many patients and their families to travel long distances to receive the highest quality of care possible.
PRACTICE SPOTLIGHT
Coastal Cancer Center
In February, OneOncology and its South Carolina-based partner, Coastal Cancer Center, acquired two radiation oncology centers in Myrtle Beach and Conway, South Carolina. This acquisition, which included four linear accelerators, and partnerships with three radiation oncologists, and forty employees, enabled Coastal Cancer Center to rapidly expand into the radiation oncology service.
With this expansion, Coastal Cancer Center now offers a comprehensive range of cancer treatments, integrating medical oncology, radiation oncology, imaging services, and an on-site pharmacy under one roof. This enhanced service offering not only improves patient convenience but also strengthens continuity of care, ensuring treatments are more coordinated and seamless — factors that contribute to better outcomes and higher patient satisfaction.
Strategically, this addition bolsters Coastal Cancer Center’s ability to be a contending force in the South Carolina oncology market. Furthermore, it enhances the practice’s financial sustainability by creating growth opportunities across diverse service lines.
Tennessee Oncology
In August, OneOncology and its Tennessee-based partner, Tennessee Oncology, collaborated with Ascension Saint Thomas Health to launch an advanced cellular therapy program offering CAR-T cell therapy. This groundbreaking treatment involves modifying a patient’s T-cells to target and destroy cancer cells, representing a cutting-edge approach to personalized cancer care.
Through this partnership, Tennessee Oncology is bringing CAR-T therapy to a patient population that previously lacked access to such innovative treatments. Natalie Dickson, MD, medical oncologist, CEO, and President of Tennessee Oncology, highlighted the program’s significance, stating, “This community-based CAR-T program is a significant step forward in our mission to provide every patient with access to the highest quality cancer care and the most advanced treatments available. By expanding the reach of CAR-T therapy into the community through this partnership, we are fulfilling our commitment to bring innovative, life-saving treatments closer to home for our patients.”